Safety update on commonly used psychotropic medications in dermatology.
It is the experience of dermatologists worldwide that a significant proportion of their patient population has underlying psychological components to their dermatologic complaints. Since these patients are often reluctant to see a mental health professional, the effective management of the underlying psychopathology may require the use of psychotropic medications by the dermatologists. This paper aims to update dermatologists on recent safety information on some of the most commonly prescribed psychotropic medications in psychodermatology. In the process it will also address the implications of these recent safety updates for prescribing clinicians.
University of California, Davis School of Medicine, Davis, CA, USA. dnavi@ucdavis.edu
Daniel
D
Navi
John
J
Koo
D000075202:Contraindications; D003880:Dermatology; D004348:Drug Labeling; D006801:Humans; D011618:Psychotic Disorders / Q000150:complications / Q000188:drug therapy*; D011619:Psychotropic Drugs / Q000009:adverse effects*; D012871:Skin Diseases / Q000150:complications / Q000523:psychology*
D011619:Psychotropic Drugs